National registry of human embryonic stem cell lines

This registry lists human pluripotent stem cell lines derived directly from embryos, in a manner consistent with TCPS 2 (2014) or, prior to December 18, 2014 to the Guidelines for Human Pluripotent Stem Cell Research. Induced human pluripotent stem cell lines will not be listed with the registry, as they are not derived from embryonic sources.

All human embryonic stem cell lines derived under the auspices of an Institution eligible for Agency funding must be listed in the registry. However, prior to June 30, 2010, only human embryonic stem cell lines derived in the course of CIHR-funded projects were required to be listed in the registry.

To date, no human embryonic stem cell lines have been derived in the course of CIHR-funded projects. Investigators with lines derived prior to June 30, 2010 under the auspices of an eligible institution voluntarily listed their cell lines.

Lines listed here will be made available by the researcher to other researchers, subject to reasonable cost-recovery charges. Note that research conducted under the auspices of an eligible institution using these cell lines must be reviewed and approved by its REB and the Stem Cell Oversight Committee (SCOC) before the work can commence.

Cell line(s) Publication citation Source Contact Information
CA1, CA2 PMID: 17572666 Dr. Andras Nagy, Mt. Sinai Hospital, Toronto Nagy Lab,
Samuel Lunenfeld Research Institute
CC1, CC3 PMID: 20555390 Dr. Derrick Rancourt, University of Calgary Dept. of Biochemistry and Molecular Biology
University of Calgary
300 Heritage Medical Research
3330 Hospital Dr. N.W.
Calgary, AB
T2N 4N1
Telephone: 403-220-2888
Email: rancourt@ucalgary.ca